|Articles|April 8, 2019
Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products
Author(s)McKesson Life Sciences
How biopharma companies can pursue multiple channels to enhance access to segmented markets.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
2
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
3
Henlius Enters Global Exclusive License Agreement with U-mab Biopharma for Best-in-Class Potential Anti-IL-1RAP mAb
4
Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma
5